Image not available in RecallScope.
Ethacrynate Sodium for Injection, USP, 50mg vial, Single Dose Vial, Rx Only
Official notice
19 Feb 2020
An official FDA notice concerns Ethacrynate Sodium for Injection, USP, 50mg vial, Single Dose Vial, Rx Only. CGMP Deviations Published 2020-02-19.
What to do now
This recall has been terminated. See the official FDA notice for the latest status.
Units affected
2,207
Recall number
D-0834-2020
Official notice
2020-02-19
The hazard
The hazard
CGMP Deviations
How to check if you’re affected
How to check if you’re affected
Compare the product name and identifiers below with the item you own. Check the official notice for the affected products and next steps.
Event Ids
Recall Numbers
Checked manually this time?
Follow brands and keywords in the app to receive alerts for matching official notices.
Turn on recall alertsAffected products
Affected products
Product 1
Units affected
Hazard
Where it was sold
Where it was sold
Retailer information is not currently available in RecallScope. Check the official notice for distribution details.
Location 1
Affected area 1
Company & contacts
Company & contacts
Brand: Zydus Pharmaceuticals. Contact: Zydus Pharmaceuticals USA Inc.
Source & status
Source & status
Recall details
Recall details
Recall number
Event ID
Units affected
Status
Source tier
Documents, notices & source
See the official notice and source documents for full details.
View full official noticeWeekly recall digest
Get next week’s recalls before you need them.
One email every Monday with official-source recalls for your country, and nothing else. Unsubscribe from any email.
The digest arrives once a week. For matching recall alerts after notices are processed, get the app.